Good morning Beasley. They are where CYDY was a little over a year ago. January will be quite eventful.
I love the FDA allowing more EIND's for leronlimab. Hopefully, the patient will have a rapid recovery and perhaps CYDY will be able to let us know.
(3)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-